Interferon alpha 2a downregulates VEGF expression through PI3 kinase and MAP kinase signaling pathways

被引:64
作者
Wu, WZ
Sun, HC
Shen, YF
Chen, J
Wang, L
Tang, ZY
Iliakis, G
Liu, KD
机构
[1] Fudan Univ, Liver Canc Inst, Shanghai 200032, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China
[3] Univ Duisburg Essen, Sch Med, Inst Med Radiat Biol, Essen, Germany
关键词
interferon alpha 2a; PI3 kinase pathway; MAP kinase pathway; VEGF; cDNA micro array; human hepatocellular carcinoma;
D O I
10.1007/s00432-004-0615-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An earlier report demonstrated that interferon alpha (IFN-alpha) inhibited tumor growth and recurrence in an MHCC97 xenograft model in nude mice by suppressing tumor angiogenesis rather than by inhibiting tumor cell proliferation. However, the underlying molecular mechanism was not fully elucidated. In this study, we demonstrated that IFN-alpha 2a could downregulate VEGF expression both in mRNA and in protein levels, as well as downregulating HIF-1alpha mRNA expression in MHCC97 cells in vitro. A cDNA micro array analysis followed by Northern and Western blot analysis revealed that PI3 kinase and MAP kinase signaling pathways might be inhibited by IFN-alpha 2a. Blocking the function of IFN-alpha receptor with a specific peptide could eliminate the inhibitory effects of IFN-alpha 2a on VEGF expression. In addition, wortmannin and PD098059, respective inhibitors of the PI3 kinase and the MAP kinase signaling pathways, when used independently or in combination, could also downregulate the VEGF synthesis and secretion in a similar pattern of IFN-alpha 2a. These observations may lead to the conclusion that IFN-alpha 2a could suppress VEGF synthesis and secretion by downregulating HIF-1alpha expression, via inhibition of the PI3 kinase and/or the MAP kinase signaling pathways.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 72 条
[11]   Transforming growth factor-β and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis [J].
Breier, G ;
Blum, S ;
Peli, J ;
Groot, M ;
Wild, C ;
Risau, W ;
Reichmann, E .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (02) :142-148
[12]   Expression of HIF-Iα by human macrophages:: implications for the use of macrophages in hypoxia-regulated cancer gene therapy [J].
Burke, B ;
Tang, N ;
Corke, KP ;
Tazzyman, D ;
Ameri, K ;
Wells, M ;
Lewis, CE .
JOURNAL OF PATHOLOGY, 2002, 196 (02) :204-212
[13]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[14]   Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway [J].
Clarke, K ;
Smith, K ;
Gullick, WJ ;
Harris, AL .
BRITISH JOURNAL OF CANCER, 2001, 84 (10) :1322-1329
[15]  
Currie MJ, 2001, CLIN CANCER RES, V7, P918
[16]  
Denis GV, 2000, CELL GROWTH DIFFER, V11, P417
[17]  
Dinney CPN, 1998, CANCER RES, V58, P808
[18]  
Dong G, 2001, CANCER RES, V61, P5911
[19]  
Folkman J, 2001, THROMB HAEMOSTASIS, V86, P23
[20]  
Folkman J, 1992, Semin Cancer Biol, V3, P89